leupeptin has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreola, ML; Baranova, SV; Buneva, VN; Calmels, C; Kharitonova, MA; Nevinsky, GA; Parissi, V; Sizyakina, LP | 1 |
| Craik, CS; Levy, JA; Mackewicz, CE | 1 |
| Brown, SA; Chaka, W; Cresswell, P; Hurwitz, JL; Sealy, R; Surman, S | 1 |
3 other study(ies) available for leupeptin and HIV Coinfection
| Article | Year |
|---|---|
HIV-1 integrase-hydrolyzing antibodies from sera of HIV-infected patients.
Topics: Adolescent; Adult; Antibodies, Catalytic; Chromatography, Affinity; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Female; HIV Infections; HIV Integrase; Humans; Hydrolysis; Leupeptins; Male; Pepstatins; Protease Inhibitors; Sulfones; Young Adult | 2009 |
The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV; HIV Infections; Humans; In Vitro Techniques; Leupeptins; Protease Inhibitors; Virus Replication | 2003 |
Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities.
Topics: Animals; Antigen Presentation; Cysteine Endopeptidases; env Gene Products, Human Immunodeficiency Virus; Erythrocyte Membrane; Histocompatibility Antigens Class II; HIV Infections; HIV-1; Humans; Hybridomas; Interferon-gamma; Interleukin-2; Leupeptins; Lymphocyte Activation; Mice; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; T-Lymphocytes, Helper-Inducer | 2008 |